Across healthcare investing and corporate strategy, Philip H. Luccock has led deal sourcing, due diligence and portfolio oversight for growth-stage companies. He combines operational experience in medical technology with capital allocation skills, structuring minority and control transactions, and guiding exit planning for strategic acquirers and financings. Prior roles include leadership in corporate development and investment teams, and his background includes business education and cross-border transaction experience. Market participants consider him a practical operator-investor who bridges clinical product development and investor return objectives.
Across healthcare investing and corporate strategy, Philip H. Luccock has led deal sourcing, due diligence and portfolio oversight for growth-stage companies. He combines operational experience in medical technology with capital allocation skills, structuring minority and control transactions, and guiding exit planning for strategic acquirers and financings. Prior roles include leadership in corporate development and investment teams, and his background includes business education and cross-border transaction experience. Market participants consider him a practical operator-investor who bridges clinical product development and investor return objectives.
Bridges clinical insight and financial discipline to source and scale growth-stage healthcare technology opportunities. Prefers minority and structured control investments that align operational support with clear exit pathways for strategic acquirers or financings. Emphasizes rigorous clinical and regulatory due diligence, capital-efficient product development milestones, and staged financings tied to technical and commercial inflection points. Time horizon is growth-stage with a three- to seven-year exit orientation; risk is managed through active portfolio oversight, governance terms, and commercialization-focused value-creation plans.
Bridges clinical insight and financial discipline to source and scale growth-stage healthcare technology opportunities. Prefers minority and structured control investments that align operational support with clear exit pathways for strategic acquirers or financings. Emphasizes rigorous clinical and regulatory due diligence, capital-efficient product development milestones, and staged financings tied to technical and commercial inflection points. Time horizon is growth-stage with a three- to seven-year exit orientation; risk is managed through active portfolio oversight, governance terms, and commercialization-focused value-creation plans.
| Trades 535 | Longs Won 305/535 57% | Profit Factor 2.12 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $419,698.97 |
| Average Win $74,424.41 | Best Trade (Jun 30) $8.61M | Sharpe Ratio -9.33 |
| Average Loss -$46,577.51 | Worst Trade (Mar 31) -$1.86M | Z-Score 0.11 (8.84%) |
| Commissions $0 | Avg. Trade Length 7m 1w 4d | Expectancy $22,406.34 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | 0.02% | 0.16% | 0.75% | 2.46% | 6.53% | 14.87% | 30.35% | 56.95% |
| Consecutive Losing Trades | 456 | 410 | 364 | 319 | 273 | 228 | 182 | 137 | 91 | 46 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 322 | $66,138.11 | $99,469.02 | - | $33,330.91 | 50.4% | -7.354% |
ALLE Allegion plc | 66 | $8,625 | $10,388.4 | - | $1,763.4 | 20.45% | +0.216% |
ALV Autoliv, Inc. | 162 | $16,371.56 | $19,953.54 | - | $3,581.98 | 21.88% | -0.797% |
AMD Advanced Micro Devices, Inc. | 212 | $30,083.07 | $100,943.8 | - | $70,860.73 | 235.55% | -1.904% |
AMZN Amazon.com Inc | 187 | $41,604.68 | $50,785.46 | - | $9,180.78 | 22.07% | +15.321% |
APA APA Corporation | 344 | $6,291.67 | $12,838.08 | - | $6,546.41 | 104.05% | +2.725% |
ATO Atmos Energy Corporation | 63 | $9,767.7 | $10,885.14 | - | $1,117.44 | 11.44% | -0.849% |
BAC Bank of America Corporation | 502 | $23,802.22 | $31,098.9 | - | $7,296.68 | 30.66% | +0.356% |
BBAI BigBear.ai Holdings Inc. | 1,000 | $6,790 | $2,790 | - | -$4,000 | -58.91% | -1.413% |
BMBL Bumble Inc. | 50 | $330 | $142.5 | - | -$187.5 | -56.82% | -2.062% |
BMNR Bitmine Immersion Technologies, Inc. | 300 | $15,579 | $5,184 | - | -$10,395 | -66.72% | -4.425% |
BP BP p.l.c. Sponsored ADR | 330 | $9,871 | $14,922.6 | - | $5,051.6 | 51.18% | +2.261% |
BTC Grayscale Bitcoin Mini Trust ETF | 55 | $2,303 | $1,529.55 | - | -$773.45 | -33.58% | -2.864% |
BWA BorgWarner Inc. | 120 | $3,815.12 | $7,648.8 | - | $3,833.68 | 100.49% | -1.04% |
CCI Crown Castle Inc. | 126 | $12,949 | $9,613.8 | - | -$3,335.2 | -25.76% | -0.274% |
CENX Century Aluminum Company | 93 | $5,459 | $4,163.61 | - | -$1,295.39 | -23.73% | -0.245% |
COIN Coinbase Global, Inc. | 35 | $8,691 | $5,119.1 | - | -$3,571.9 | -41.1% | -10.588% |
COST Costco Wholesale Corporation | 205 | $199,561.93 | $195,137.45 | - | -$4,424.48 | -2.22% | -0.239% |
COTY Coty Inc. | 30 | $209 | $82.5 | - | -$126.5 | -60.53% | +2.23% |
CRML Critical Metals Corp. | 100 | $694 | $549 | - | -$145 | -20.89% | -1.259% |